CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
64.45
-4.19 (-6.10%)
Mar 18, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Biotechnology
4.04M1.14M204.00K191.00K10.36M
Biotechnology Growth
254.70%458.33%6.81%-98.16%-
Total
4.04M1.14M204.00K191.00K10.36M
Total Growth
254.70%458.33%6.81%-98.16%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
4.04M1.14M204.00K191.00K10.36M
United States Growth
254.70%458.33%6.81%-98.16%-
Total
4.04M1.14M204.00K191.00K10.36M
Total Growth
254.70%458.33%6.81%-98.16%-
Source: S&P Global Market Intelligence.